Taijyu Satoh
Overview
Explore the profile of Taijyu Satoh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Satoh T, Yaoita N, Higuchi S, Nochioka K, Yamamoto S, Sato H, et al.
Pulm Circ
. 2024 Dec;
14(4):e70026.
PMID: 39678732
Patients with borderline pulmonary hypertension (PH) often experience shortness of breath or exacerbation of PH during exercise, known as exercise-induced PH. However, the pathogenesis of exercise-induced post-capillary PH (post-EIPH) and...
2.
Satoh T, Yaoita N, Higuchi S, Nochioka K, Yamamoto S, Sato H, et al.
JACC Cardiovasc Interv
. 2024 Oct;
17(20):2394-2407.
PMID: 39477643
Background: Balloon pulmonary angioplasty (BPA) has exhibited substantial progress in the management of chronic thromboembolic pulmonary hypertension (CTEPH). However, nearly one-half of the patients with CTEPH experience persistent pulmonary hypertension...
3.
Suzuki H, Inoue T, Terui Y, Takeuchi K, Susukita K, Arai M, et al.
ESC Heart Fail
. 2024 Apr;
11(4):2451-2454.
PMID: 38685602
Aims: Vericiguat has been used to treat patients with heart failure with reduced ejection fraction (HFrEF) who demonstrated worsening heart failure despite treatment with other guideline-directed medical therapies. The haemodynamic...
4.
Tai Y, Yu Q, Tang Y, Sun W, Kelly N, Okawa S, et al.
Sci Transl Med
. 2024 Jan;
16(729):eadd2029.
PMID: 38198571
Hypoxic reprogramming of vasculature relies on genetic, epigenetic, and metabolic circuitry, but the control points are unknown. In pulmonary arterial hypertension (PAH), a disease driven by hypoxia inducible factor (HIF)-dependent...
5.
Terui Y, Suzuki H, Chikata A, Hanaki Y, Komatsu Y, Ota H, et al.
Intern Med
. 2023 Nov;
63(12):1725-1731.
PMID: 37926544
We herein report a 37-year-old man who experienced recurrence of metastatic cardiac rhabdomyosarcoma along with intractable ventricular tachycardia (VT) 7 years after resection of rhabdomyosarcoma in his right elbow. At...
6.
Satoh T, Yaoita N, Nochioka K, Tatebe S, Hayashi H, Yamamoto S, et al.
ESC Heart Fail
. 2023 Sep;
10(6):3592-3603.
PMID: 37775984
Aims: The pathophysiology of pulmonary hypertension (PH) due to left-sided heart disease (Group 2 PH) is distinct from that of other groups of PH, yet there are still no approved...
7.
Higuchi S, Ota H, Yaoita N, Kamada H, Takagi H, Satoh T, et al.
J Cardiol
. 2022 Apr;
81(3):297-306.
PMID: 35490106
Chronic thromboembolic pulmonary hypertension (CTEPH), classified as group 4 pulmonary hypertension (PH), is caused by stenosis and obstruction of the pulmonary arteries by organized thrombi that are incompletely resolved after...
8.
Negi V, Yang J, Speyer G, Pulgarin A, Handen A, Zhao J, et al.
Sci Adv
. 2021 Oct;
7(43):eabh3794.
PMID: 34669463
Cancer therapies are being considered for treating rare noncancerous diseases like pulmonary hypertension (PH), but effective computational screening is lacking. Via transcriptomic differential dependency analyses leveraging parallels between cancer and...
9.
Satoh T, Wang L, Espinosa-Diez C, Wang B, Hahn S, Noda K, et al.
Circulation
. 2021 Jun;
144(8):615-637.
PMID: 34157861
Background: Many patients with heart failure with preserved ejection fraction have metabolic syndrome and develop exercise-induced pulmonary hypertension (EIPH). Increases in pulmonary vascular resistance in patients with heart failure with...
10.
Culley M, Zhao J, Tai Y, Tang Y, Perk D, Negi V, et al.
J Clin Invest
. 2021 Apr;
131(11).
PMID: 33905372
The dynamic regulation of endothelial pathophenotypes in pulmonary hypertension (PH) remains undefined. Cellular senescence is linked to PH with intracardiac shunts; however, its regulation across PH subtypes is unknown. Since...